GPX4 and neoplasm: In addition, NFE2L1 was recently shown to suppress ferroptosis in OSCC by transcriptionally upregulating HJURP, which stabilizes GPX4 and SLC7A11 expression and reduces lipid ROS accumulation, thereby promoting tumor growth and ferroptosis resistance [81].